CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
12.13
-0.33 (-2.65%)
At close: Aug 13, 2025, 4:00 PM
12.19
+0.06 (0.49%)
After-hours: Aug 13, 2025, 7:03 PM EDT
CareDx Employees
As of December 31, 2024, CareDx had 650 total employees, including 644 full-time and 6 part-time employees. The number of employees increased by 7 or 1.09% compared to the previous year.
Employees
650
Change (1Y)
7
Growth (1Y)
1.09%
Revenue / Employee
$524,348
Profits / Employee
$89,445
Market Cap
645.64M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CDNA News
- 6 days ago - CareDx, Inc (CDNA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - CareDx Announces Appointment of Nathan Smith as Chief Financial Officer - Business Wire
- 7 days ago - CareDx Announces Second Quarter 2025 Financial Results - Business Wire
- 7 days ago - CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation - Business Wire
- 13 days ago - CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress - Business Wire
- 21 days ago - CareDx to Report Second Quarter 2025 Financial Results - Business Wire
- 26 days ago - CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection - Business Wire
- 2 months ago - CareDx: The Transplant Diagnostics Leader, But Challenges Will Increase On The Road Ahead - Seeking Alpha